Dual bronchodilator response according to bronchitis symptoms in the FLAME study

A. Mackay (London, United Kingdom), K. Kostikas (Basel, United Kingdom), S. Frent (Timisoara, Romania), K. Mezzi (Basel, United Kingdom), P. Pfister (Basel, United Kingdom), P. Gupta (Hyderabad, United Kingdom), F. Patalano (Basel, United Kingdom), D. Banerji (East Hanover, United Kingdom), J. Wedzicha (London, United Kingdom)

Source: International Congress 2018 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 4375
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mackay (London, United Kingdom), K. Kostikas (Basel, United Kingdom), S. Frent (Timisoara, Romania), K. Mezzi (Basel, United Kingdom), P. Pfister (Basel, United Kingdom), P. Gupta (Hyderabad, United Kingdom), F. Patalano (Basel, United Kingdom), D. Banerji (East Hanover, United Kingdom), J. Wedzicha (London, United Kingdom). Dual bronchodilator response according to bronchitis symptoms in the FLAME study. 4375

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Baseline symptom burden and dual bronchodilator response in the FLAME study
Source: International Congress 2018 – COPD management
Year: 2018


The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014



Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020


Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Bronchodilator response in adult-onset asthma according to age
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Late Breaking Abstract - Effect of inhaled corticosteroids on exacerbation of asthma–COPD overlap according to different diagnostic criteria
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019


Impact of Bronchial Rheoplasty on exacerbations in chronic bronchitis: a US feasibility study
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021


Evaluation of vibration response imaging (VRI) in COPD and asthma patients before and after bronchodilators
Source: Eur Respir J 2007; 30: Suppl. 51, 100s
Year: 2007

Effect of high extrafine strength (HS) ICS-containing triple therapy on exacerbations in patients with severe asthma and persistent airflow limitation: Post-hoc analysis of the TRIGGER study
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019



Analysis of bronchodilator response in patients with controlled asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 223s
Year: 2004

Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study
Source: International Congress 2017 – Asthma management
Year: 2017


Comparable effectiveness of budesonide/formoterol combination and fluticasone for the treatment of cough variant asthma
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013


Evaluating acute bronchodilator response with subjective and objective criteria in stable COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 64s
Year: 2005

The bronchitis severity scale (BSS): A validated tool to assess the effect of pharmacotherapy in acute bronchitis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Omalizumab added to best standard care reduces exacerbations in patients with severe persistent asthma according to GINA 2002 classification
Source: Eur Respir J 2004; 24: Suppl. 48, 220s
Year: 2004

Improvement in symptoms, wheezing and pulmonary function tests of asthmatic patients due to application of GINA in their treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 842s
Year: 2006

Lung function change and exacerbations in patients with COPD in the WISDOM study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2009 - Accuracy in lung function testing
Year: 2009

Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma
Year: 2006